Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer's disease

Artem Zatcepin1,2, Johannes Gnörich3,4, Boris-Stephan Rauchmann5,6

  • 1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. Artem.Zatcepin@med.uni-muenchen.de.

Molecular Neurodegeneration
|September 5, 2024
PubMed
Abstract

Insights

Microglial desynchronization, assessed via TSPO-PET imaging, shows promise as a biomarker for Alzheimer's disease (AD) progression and cognitive decline. This study reveals a potential "microglia connectome" linked to neurodegeneration.

Area of Science:

  • Neuroscience
  • Neuroimaging
  • Biomarker Discovery

Background:

  • Microglial activation is a key feature of Alzheimer's disease (AD) neuropathology.
  • The regional interplay and synchronization of microglia in the brain remain poorly understood.
  • This study investigates microglial desynchronization as a potential AD biomarker.

Purpose of the Study:

  • To explore the existence of a "microglia connectome" and its alterations in AD.
  • To investigate microglial desynchronization as a potential biomarker for AD progression.
  • To correlate microglial desynchronization with cognitive performance in AD patients.

Main Methods:

  • Microglia depletion in mice to assess 18 kDa translocator protein (TSPO)-PET interregional correlation coefficients (ICCs).
  • Evaluation of dysfunctional microglia and AD pathophysiology on TSPO-PET ICCs in mouse models.
  • Translation to a human AD-continuum dataset and correlation with cognitive performance.
  • Single-cell radiotracing (scRadiotracing) in mice to confirm the microglial source of desynchronization.

Main Results:

  • Microglia depletion led to significant reductions in TSPO-PET ICCs, confirming microglia-specific desynchronization.
  • AD mouse models showed reduced microglial synchronicity, linked to increased radiotracer uptake variability.
  • Human AD-continuum data revealed stage-dependent reductions in microglia synchronicity correlating with cognitive decline.
  • scRadiotracing confirmed microglia as the source of the observed TSPO signal.

Conclusions:

  • First evidence for assessing a microglia connectome in the mouse brain using TSPO-PET imaging and scRadiotracing.
  • Microglial synchronicity is closely associated with cognitive decline in Alzheimer's disease.
  • Microglial desynchronization may serve as an independent, personalized biomarker for AD progression.